Status:
COMPLETED
Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Febrile Illness
Malaria
Eligibility:
All Genders
1-11 years
Brief Summary
Malaria remains a disease that causes much death and sickness, especially in sub-Saharan Africa. An accurate, simple, and inexpensive method of diagnosing malaria is urgently needed. The purpose of th...
Detailed Description
Malaria remains one of the most devastating infectious diseases, causing high morbidity and mortality especially in sub-Saharan Africa. The need for an accurate, simple, and inexpensive method to diag...
Eligibility Criteria
Inclusion
- Member of the cohort participating in clinical trial of antimalarial drug efficacy in Kampala, which was enrolled based on criteria including the following characteristics:
- Ages 1-10 (at time of original enrollment)
- Parents' or guardians' agreement to bring the child to the study clinic for any fevers or other illnesses
- Agreement to avoid medications administered outside the study
- Intention to remain in Kampala for the full study period
- Native Ugandan
Exclusion
- Presence of any known serious chronic disease (e.g. AIDS, sickle cell disease, malignancy)
- Serious side effects to study medications used in cohort clinical trial of antimalarial drug efficacy
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00327964
Start Date
October 1 2005
End Date
May 1 2006
Last Update
February 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mulago Hospital
Kampala, Uganda